<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PARALDEHYDE</span><br/>(par-al'de-hyde)<br/><span class="topboxtradename">Paral<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">anticonvulsant</span>; <span class="classification">sedative-hypnotic</span>; <span class="classification">barbiturate</span><br/><b>Prototype: </b>Phenobarbital<br/><b>Pregnancy Category: </b>C<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 g/mL liquid</p>
<h1><a name="action">Actions</a></h1>
<p>Cyclic ether formed by polymerization of acetaldehyde.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Potent CNS depressant with sedative and hypnotic actions similar to those of alcohol, barbiturates, and chloral hydrate.</p>
<h1><a name="uses">Uses</a></h1>
<p>Sedative and hypnotic in acute agitation due to alcohol withdrawal; used to control convulsions arising from tetanus, eclampsia,
         Status Epilepticus, and drug poisoning. Has been used rectally to induce basal anesthesia, particularly in children.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Severe hepatic insufficiency; respiratory disease; GI inflammation or ulceration; disulfiram therapy; pregnancy (category
         C), lactation.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Hypnotic</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1030 mL prn<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 0.3 mL/kg<br/><br/><span class="indicationtitle">Sedative</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 510 mL prn<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 0.15 mL/kg<br/><br/><span class="indicationtitle">Seizures Secondary to Tetanus</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> up to 12 mL diluted 1:10 q4h prn<br/><br/><span class="indicationtitle">Seizures Secondary to Other Poisons</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PR</span> 515 mL diluted in 200 mL per rectal tube<br/><br/><span class="indicationtitle">Status Epilepticus</span><br/><span class="rdage">Child:</span> <span class="rdroute">PR</span> 1 mL/y of age up to 5 mL; may repeat in 1 h if necessary, then change to PO. PO 25 mL q24h<br/><br/><span class="indicationtitle">Alcohol Withdrawal Seizures</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 510 mL q46h for 24 h, then q6h prn<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<p> 			Note: Both oral and rectal doses must be diluted before they are administered. 		</p><span class="adminroutetype">Oral/</span><span class="adminroutetype">Rectal</span><br/><ul>
<li> 				Note: On exposure to light, air, and heat, drug liberates acetaldehyde, which oxidizes to acetic acid. Do not use solution if it
            is colored in any way or smells of acetic acid (vinegar odor). 			
         </li>
<li>Discard unused contents of any container that has been open for more than 24 h. Decomposed paraldehyde is extremely corrosive
            to tissues and can cause fatal poisoning.
         </li>
<li>Do not use plastics for measuring or administering paraldehyde. Contact with plastic materials can decompose paraldehyde to
            toxic compounds. Draw parenteral preparation into a glass syringe; use rubber catheter for rectal administration.
         </li>
<li>Give oral drug well diluted in iced fruit juice or milk to reduce irritation of GI tract and mask odor and taste.</li>
<li>When given rectally, dilute drug with at least 2 volumes of olive oil or cottonseed oil or dissolved in 200 mL of NS solution
            to prevent rectal irritation.
         </li>
<li>Do not withdraw rapidly after prolonged use; may produce delirium tremens and hallucinations.</li>
<li>Preserve in tight, light-resistant containers in amounts not exceeding 30 mL and at temperatures not over 25° C (77°
            F).
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Occasionally confusion and paradoxical excitement. <span class="typehead">CNS:</span> Hangover, dizziness, ataxia. <span class="typehead">CV:</span> Hypotension, <span class="speceff-life">dilation and failure of right heart, cardiovascular collapse</span>. <span class="typehead">GI:</span> <span class="speceff-common">Irritation of mucous membrane (oral and rectal routes),</span> nausea, vomiting, unpleasant taste and odor, <span class="speceff-life">toxic hepatitis</span>, bleeding gastritis, liver damage. <span class="typehead">Urogenital:</span> Nephrosis, renal damage. <span class="typehead">Metabolic:</span> Metabolic acidosis, acidosis. <span class="typehead">Respiratory:</span> Rapid labored breathing, <span class="speceff-life">respiratory depression</span>, pulmonary hemorrhage and edema. <span class="typehead">Skin:</span> <span class="speceff-common">Erythematous skin rash.</span>
<h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Chronic use of alcohol (ethanol) and paraldehyde may cause false-positive <span class="alt">serum ketones (nitroprusside tube dilution method)</span> and <span class="alt">urine ketones (Acetest)</span> and may interfere with <span class="alt">urinary steroid (17-OHCS) determinations</span> by modification of <span class="alt">Reddy,</span> <span class="alt">Jenkins,</span> <span class="alt">Thorn procedure.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Disulfiram</b> may increase paraldehyde levels; <b>alcohol</b> and other <span class="classification">cns depressants</span> add to CNS depressant effectsfatalities reported with <b>alcohol.</b>
<h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 1015 min. <span class="typehead">Duration:</span> 68 h. <span class="typehead">Distribution:</span> Distributed into CNS; crosses placenta. <span class="typehead">Metabolism:</span> 8090% of doses metabolized in liver. <span class="typehead">Elimination:</span> Excreted through lungs (1128%) and urine. <span class="typehead">Half-Life:</span> 7.5 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor cardiovascular and respiratory status closely.</li>
<li>Keep the patient turned on side to prevent aspiration since bronchial secretions may be increased. Suctioning may be necessary.</li>
<li>Be aware that patient's breath will have a characteristic odor for several hours.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>